No Detail Found!

Assessment of pharmacist-driven QT interval prolongation in cardiac patients: Application of Framingham's heart rate corrected QT interval formula and the Tisdale risk score

Author(s)
Ahmad Ullah Humza Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Pakistan
Sadia Ghousia Baig Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Pakistan
Zafar Iqbal National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Gul Sama National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Imran Ahmed National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Amna Hamza Abdali Institute of Nursing and Health Sciences,Karachi,Pakistan
Abstract
QTc interval prolongation is a clinical concern in critically ill cardiac patients. Pharmacist-driven approaches that utilize accurate QTc interval measurements and risk stratification tools are essential for identifying high-risk patients and preventing arrhythmic events. This study evaluates the application of Framingham's heart rate corrected QT interval (QTc) formula and the Tisdale risk score for identifying QTc interval prolongation. This prospective observational study was conducted at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. A total of 485 patients were analyzed. Of 485 patients, 71 (14.6%) exhibited QTc interval prolongation. Among them, 6 (1.2%) exhibited severe QTc interval prolongation, with values >500 ms. The Tisdale risk score classified 67.6% of the patients as high-risk before the intervention, and reduced to 36.6% post-intervention. Older patients (=60 years) were significantly more likely to exhibit QTc interval prolongation, particularly in the >500 ms. Risk factors for QTc interval prolongation included female sex, hypokalemia, and the use of multiple QTc interval prolonging medications. This study underscores the importance of combining Framingham's formula and the Tisdale risk score, with pharmacist involvement, to accurately assess QTc interval prolongation and optimize patient management, enhancing safety and reducing arrhythmic risk in critically ill cardiac patients.
Publication Details
Page(s) 1539-1546
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
Pakistan, Tisdale, QTc interval prolongation, Framingham's QTc interval correction formula, torsade de pointes
References
Al-Azayzih A,Al-Qerem W,Al-Azzam S,Muflih S,AlHusein BA,Kharaba Z,Kanaan RJ,Rahhal D .2024 .Prevalence of medication associated with QTc prolongation used among critically Ill patients. Vasc. Health Risk Manag., 20 : 27-37.
Andršová I,Hnatkova K,Šišáková M,Toman O,Smetana P,Huster KM,Barthel P,Novotný T,Schmidt G,Malik M .2021 .Influence of heart rate correction formulas on QTc interval stability. Sci. Rep, 11(1) : 14269.
Dogan A,Tunc E,Varol E,Ozaydin M,Ozturk M M .2005 .Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men. , 10(2) : 134-141.
Farzanegan B,Hosseinpoor Z,Baniasadi S,Seyyedi SR,Rajabi M .2020 .An observational study of QTc prolongation in critically ill patients: Identification of incidence and predictors. Indian J. Crit. Care Med, 24(4) : 270-275.
Fernandes FM,da Silva Paulino AM,Sedda BC,da Silva EP,Martins RR,Oliveira AG .2019 .Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to Intensive Care Units. , 27(2) : 229-234.
Fernandes FM,Silva EP,Martins RR,Oliveira AG .2018 .QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications. PloS One, 13(6) : 1-12.
Gervasi SF,Bianco M,Palmieri V,Cuccaro F,Zeppilli P F .2017 .QTc interval in adolescents and young athletes: influence of correction formulas. Int. J. Sports Med, 38(10) : 729-734.
Harb K,Schwartz S,Cooper J .2024 .Pharmacist reported protocols for QTc monitoring of psychiatric medications. J. Cureus., 16(3) : 1-8.
Humza AU,Akbar MA,Bilal Awan MA,Yousuf JB,Khan K,Ammar A .2024 .Prevalence and comparative analysis of potential drug-drug interactions among hospitalized patients at a tertiary care cardiac institute in Pakistan: Findings from a single centre. Pak. J. Pharm. Sci., 37(5) : 961-968.
Humza AU,Hameed A,Akbar MA,Ahmed I,Ali A,Yousuf JB .2024 .Evaluation of medication use and polypharmacy in postoperative cardiac patients: The clinical pharmacist's imperative in a public institute of Pakistan. Pak. J. Pharm. Sci, 37(1) : 17-23.
Humza AU,Siddiq A,Baig SG,Ali A,Ahmed I,Yousuf JB .2024 .Assessment of QTc-interval prolonging medication utilization and associated potential drug-drug interactions in hospitalized cardiac patients: A cross-sectional study in cardiology. Jordan J. Pharm. Sci., 17(3) : 603-610.
Kheshti R,Aalipour M,Namazi S M .2016 .A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J. Res. Pharm. Pract, 5(4) : 257-263.
Lima B,Razmjouei S,Bajwa MT,Shahzad Z,Shoewu OA,Ijaz O,Mange P,Khanal S,Gebregiorgis T .2023 .Polypharmacy, gender disparities and ethnic and racial predispositions in long QT syndrome: An in-depth review. Cureus., 15(9) : 1-22.
Neto NRDO,De Oliveira WS,Pinto GDC,De Oliveira ESR,Maria das Neves D ESR .2020 .A practical method for QTc interval measurement. Cureus, 12(12) : 1-7.
Newell B,Wirick N,Rigelsky F,Migal K F .2021 .Implementation of a Pharmacist Monitoring Process for Patients on QTc Prolonging Antibiotics: A Pilot Study. , 56(6) : 772-776.
Rossi M,Marzi F,Natale M,Porceddu A,Tuccori M,Lazzerini PE,Laghi-Pasini F,Capecchi PL .2021 .Drug-associated QTc prolongation in geriatric hospitalized patients: A cross-sectional study in internal medicine. Drugs-real world outcomes.,, 8 : 325-335.
Simon ST,Lin M,Trinkley KE,Aleong R,Rafaels N,Crooks KR,Reiter MJ,Gignoux CR,Rosenberg MA .2024 .A polygenic risk score for the QT interval is an independent predictor of drug-induced QT prolongation. PloS One, 19(6) : 1-15.
Skullbacka S,Airaksinen M,Puustinen J,Toivo T .2022 .Risk assessment tools for QT prolonging pharmacotherapy in older adults: A systematic review. Eur. J. Clin. Pharmacol, 78(5) : 765-779.
Steinbrech J,Amann U,Irlbeck M,Clauß S,Strobach D S .2025 .Risk stratification of QTc prolongations in hospitalized cardiology and gastroenterology patients using the tisdale score-a retrospective analysis. J. Clin. Med, 14(2) : 339.
Su K,McGloin R,Gellatly RM .2020 .Predictive validity of a QTc interval prolongation risk score in the intensive care unit. Pharmacotherapy: J. Hum. Pharmacol. Drug Ther, 40(6) : 492-499.
Tisdale JE,Jaynes HA,Kingery JR,Mourad NA,Trujillo TN,Overholser BR,Kovacs RJ,Outcomes RJ .2013 .Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ. Cardiovasc. Qual., 6(4) : 479-487.
Vandenberk B,Vandael E,Robyns T,Vandenberghe J,Garweg C,Foulon V,Ector J,Willems R,Am R .2016 .Which QT correction formulae to use for QT monitoring. , 5(6) : 1-10.
Wang H,Shi H,Wang N,Wang Y,Zhang L,Zhao Y,Xie J .2022 .Prevalence of potential drug- drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital. BMC Pharmacol, 23(1) : 39.
Woosley RG T,Woosley D,Romero KA,Tucson KA,AZCERT KA .2023 .. QTdrugs list, : .
Yazdanpanah MH,Naghizadeh MM,Sayyadipoor S,Farjam M .2022 .The best QT correction formula in a non-hospitalized population: The Fasa PERSIAN cohort study. BMC Cardiovas, 22(1) : 1-12.
0

Citations

0

Downloads

136

Views